HighMark Wealth Management’s Horizon Kinetics Medical ETF MEDX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$5.56K Hold
167
﹤0.01% 364
2025
Q4
$5.54K Buy
167
+2
+1% +$65 ﹤0.01% 392
2025
Q3
$4.93K Hold
165
﹤0.01% 399
2025
Q2
$4.4K Hold
165
﹤0.01% 410
2025
Q1
$4.57K Hold
165
﹤0.01% 381
2024
Q4
$4.31K Buy
165
+3
+2% +$86 ﹤0.01% 393
2024
Q3
$4.95K Hold
162
﹤0.01% 404
2024
Q2
$4.83K Hold
162
﹤0.01% 393
2024
Q1
$4.82K Buy
162
+9
+6% +$263 ﹤0.01% 380
2023
Q4
$4.27K Hold
153
﹤0.01% 395
2023
Q3
$4.47K Hold
153
﹤0.01% 366
2023
Q2
$4.67K Hold
153
﹤0.01% 370
2023
Q1
$4.58K Buy
+153
New +$4.58K ﹤0.01% 414

Other funds holding MEDX

HighMark Wealth Management's MEDX Position: Q1 2026 in Review

HighMark Wealth Management held its Horizon Kinetics Medical ETF (MEDX) position steady in Q1 2026 at 167 shares worth $5.56K. The position accounts for ﹤0.01% of the portfolio, ranked #364.

HighMark Wealth Management first reported a position in MEDX in Q1 2023 and has held it in 13 quarters since. 6 funds tracked by Wall St. Rank hold MEDX as of Q1 2026.

  • HighMark Wealth Management held 167 shares of Horizon Kinetics Medical ETF worth $5.56K as of Q1 2026.
  • HighMark Wealth Management left its Horizon Kinetics Medical ETF share count unchanged in Q1 2026.
  • Horizon Kinetics Medical ETF made up ﹤0.01% of HighMark Wealth Management's portfolio in Q1 2026, its #364 holding.
  • HighMark Wealth Management first reported a position in Horizon Kinetics Medical ETF in Q1 2023 and has held it in 13 quarters since.
  • 6 funds tracked by Wall St. Rank held Horizon Kinetics Medical ETF as of Q1 2026.

Based on HighMark Wealth Management's 13F filing for Q1 2026, filed 6 May 2026.